Purpose: To report our 5-year experience with intra-arterial chemotherapy (IAC) in the intravitreal chemotherapy (IvitC) era.
Methods: Retrospective review of retinoblastoma treated with primary unilateral IAC in the IvitC era (2012-2017).
Results: There were 34 eyes treated with IAC alone versus 20 eyes treated with IAC plus IvitC for vitreous seeds.